ISO 20688-2:2024 PDF

Overview

ISO 20688-2:2024 is an international standard that specifies comprehensive requirements for the production and quality control of synthesized double-stranded DNA, including gene fragments, genes, and genomes. The standard encompasses best practices for quality management, resource management, biosafety, biosecurity, and delivered product specifications within the biotechnology sector. It applies to synthetic DNA products up to 10 megabase pairs (Mbp) in length, covering both non-clonal (linear) and clonal (circular) forms. While ISO 20688-2 focuses on DNA for general biotechnological use, it defers specific requirements for materials used solely in diagnostics to related clinical standards such as ISO 15189 and ISO 13485.

Key Topics

Quality Management

• Establishment and documentation of order processing, biosafety and biosecurity risk assessment, synthesis processes, and product quality control.
• Maintenance of a robust quality policy and objectives relevant to each production process and final DNA product form.
• Procedures for controlling and safeguarding customer and order information, including electronic data security and document management.

Resource Management

• Requirements for appropriate facilities, environmental controls (temperature, humidity, cleanliness), and measures to prevent contamination of synthetic DNA.
• Use of calibrated and well-maintained equipment operated by trained personnel.
• Strict control over raw materials, suppliers, and reagent qualification to ensure consistent synthesis quality.

Biosafety and Biosecurity

• Adoption of risk- and evidence-based approaches for laboratory biosafety and biosecurity (referencing ISO 35001 and WHO guidance).
• DNA sequence screening mechanisms to assess and mitigate risks of synthesizing regulated or sensitive genetic elements.
• Recordkeeping and verification of intended use for regulated sequences and customer identities.

Production Quality Control

• Clearly defined quality control procedures for gene fragments, genes, and genomes, including design, assembly, purification, and preservation practices.
• Requirements for product yield, purity, sequence accuracy, and integrity at each stage of DNA synthesis.
• Specific protocols for sequence verification and impurity analysis for end products.

Delivered Product Specifications

• Clear documentation of delivered materials, including product information, sequence details, quality control data, and shipment records.
• Guidance on preservation and storage suitable for different forms of synthetic DNA.

Applications

ISO 20688-2:2024 plays a critical role in biotechnology research, industrial applications, and commercial DNA synthesis. Key application areas include:

• Protein engineering: Enabling the production of synthetic genes for protein expression.
• Metabolic pathway engineering: Supporting the assembly of complex genetic circuits for optimized microbial or cellular production.
• Antibody and vaccine development: Ensuring high-quality synthesized genes and fragments for biopharmaceutical research and manufacturing.
• Environmental biotechnology: Facilitating the creation of synthetic genomes for bioremediation organisms.
• Synthetic biology: Standardizing the production of custom genomes and libraries for foundational research and product development.

The standard supports manufacturers, academic laboratories, and end users in verifying and ensuring the consistent quality of synthesized double-stranded DNA. By complying with ISO 20688-2, organizations improve reliability, biosafety, and facilitate fair trade of synthetic genetic materials globally.

Related Standards

For specialized or additional requirements, the following ISO standards are relevant:

• ISO 20688-1: Biotechnology – Nucleic acid synthesis – Terminology and classification.
• ISO 15189: Medical laboratories – Requirements for quality and competence (for diagnostic applications).
• ISO 13485: Medical devices – Quality management systems (applicable for clinical diagnostics).
• ISO 35001: Biorisk management for laboratories and related organizations.
• ISO 20397 series: Biotechnology – Massively parallel sequencing.

ISO 20688-2:2024 provides a unified framework to ensure global standards in the production and quality control of synthetic gene fragments, genes, and genomes, reinforcing trust and reliability in biotechnological innovations.